Maharashtra Chief Minister Devendra Fadnavis chaired the inaugural meeting of the board of directors of the Maharashtra Cancer Care, Research and Education Foundation (MAHACARE) on Thursday, 16 July 2026, during which the foundation signed a landmark Memorandum of Understanding with the Tata Memorial Centre (TMC) to build a comprehensive cancer hospital and research programme across the state.

Context

The Chief Minister's Office of Maharashtra announced that the MoU establishes 'a collaborative framework between MAHACARE Foundation and Tata Memorial Centre for the planning, development, establishment, operation and advancement of a comprehensive Cancer Hospital and Cancer Research Program in the State of Maharashtra.' Under the agreement, Tata Memorial Centre will serve as the 'Technical and Knowledge Partner' to provide guidance, expertise and support in oncology services, training, research, infrastructure planning and capacity building.

The meeting was attended by Minister Prakash Abitkar, Minister of State Madhuri Misal, and Dr. Ajay Chandanwale, CEO of the MAHACARE Foundation, along with senior government officials.

Policy Backdrop

Tata Memorial Centre, a premier national cancer institute operating under the Department of Atomic Energy, has long been a cornerstone of India's oncology infrastructure. In 2012, TMC launched the National Cancer Grid — a network connecting oncology centres across India for collaborative care, training and research — making it a natural institutional partner for state-level cancer expansion programmes.

Maharashtra's decision to anchor MAHACARE's technical framework around TMC mirrors similar partnerships the institute has undertaken with other states in recent years, reflecting a broader national push to decentralise high-quality cancer care beyond major metropolitan centres.

Stakeholders and Impact

The agreement is expected to directly benefit cancer patients across Maharashtra, particularly those in districts that currently lack access to advanced oncology services and must travel to Mumbai or other metros for treatment. By embedding TMC's expertise into a dedicated state foundation, the arrangement positions Maharashtra to build capacity in oncology training and research at a regional level.

Oncology researchers and medical professionals in the state stand to gain through structured training modules and knowledge-transfer programmes that the MoU envisions. The creation of a dedicated state foundation — MAHACARE — also signals institutional commitment beyond a single hospital project, providing a governance structure for long-term cancer care planning.

What's Next

The immediate priorities following the MoU signing will be site selection, infrastructure planning and the rollout of the first training and research modules in collaboration with Tata Memorial Centre. The MAHACARE Foundation's newly constituted board, now formally activated under CM Fadnavis's chairmanship, will oversee these milestones. How swiftly the partnership translates into ground-level hospital construction and patient services will determine whether Maharashtra's model becomes a template for other states seeking to expand equitable cancer care.